ArticleBMC cardiovascular disorders2026
Development of a nomogram with machine learning-assisted feature selection for predicting left atrial appendage thrombosis and severe spontaneous echo contrast in patients with non-paroxysmal atrial fibrillation.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThe left atrial appendage (LAA) is the primary source of thromboembolic events in patients with non-valvular atrial fibrillation (NVAF). Therefore, detection of LAA thrombosis and severe spontaneous echo contrast (SEC) is crucial for risk stratification and management of patients with NVAF.
methodsWe retrospectively enrolled 327 patients with non-paroxysmal NVAF and collected 34 clinical and echocardiographic variables. Three machine learning approaches (SVM-RFE, Boruta, and LASSO) were employed for feature selection to construct logistic regression models. Model performance was evaluated using receiver operating characteristic (ROC) curves, calibration curves, decision curve analysis (DCA), and clinical impact curves (CIC). Reclassification analysis was performed using net reclassification improvement (NRI) and integrated discrimination improvement (IDI).
resultsLAA thrombosis or severe SEC was detected in 40 (12.2%) patients. The three machine learning algorithms demonstrated comparable area under the curve (AUC) performance, with values of 0.88 for SVM-RFE, 0.89 for LASSO, and 0.89 for Boruta. The final nomogram was constructed using variables selected by all three machine learning models. It achieved an AUC of 0.88 (95% CI: 0.83–0.93), which was significantly higher than that of the CHA2DS2-VASc score (AUC = 0.68, p < 0.001). DCA and CIC analyses showed high net benefits across a wide range of threshold probabilities. Reclassification analysis revealed an NRI of 0.957 and IDI of 0.254 (both p < 0.001) when compared with the CHA2DS2-VASc score.
conclusionsThis exploratory study suggests that the proposed nomogram may help estimate the risk of LAA thrombosis/severe SEC in patients with non-paroxysmal NVAF. The model may be useful for risk stratification and may inform clinical decision-making regarding the necessity of TEE in patients with non-paroxysmal NVAF, but its clinical reliability requires further validation in larger, independent, prospective cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.